Skip to main content
Equibles

MORGAN STANLEY

Position in CLLS — Cellectis S.A.

CIK 895421 NEW YORK, NY
Back to CLLS Full portfolio

Position in CLLS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$256,365
-$18,714 QoQ
Shares Held
85,455
-1.5% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 27 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in CLLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. CLLS ranks #312 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in CLLS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $256,365 85,455
2026-03-31 $275,079 86,776
2025-12-31 $421,930 87,176
2025-09-30 $249,872 87,675
2025-06-30 $141,511 92,795
2025-03-31 $107,625 86,795
2024-12-31 $357,647 198,694
2024-09-30 $194,032 91,525
2024-06-30 $161,426 86,325
2024-03-31 $222,983 84,145
2023-12-31 $234,772 76,225
2023-09-30 $106,795 67,592
2023-06-30 $151,834 77,152
2023-03-31 $149,964 77,702
2022-12-31 $155,695 74,141
2022-09-30 $173,931 75,953
2022-06-30 $282,860 99,951
2022-03-31 $374,139 82,410
2021-12-31 $974,131 119,967
2021-09-30 $1,618,518 128,352
2021-06-30 $1,776,882 114,860
2021-03-31 $5,216,239 258,102
2020-12-31 $8,299,950 306,724
2020-09-30 $9,665,175 522,442
2020-06-30 $14,233,519 799,636
2020-03-31 $6,636,364 721,344